Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Autoimmune Disorders

Free Subscription 03.11.2025 1 Ann Neurol 1 BMC Neurol 1 Brain 1 Curr Opin Immunol 12 Diabetes Res Clin Pract 2 Intern Med 1 J Autoimmun 1 J Clin Endocrinol Metab 1 J Immunol 6 J Neuroimmunol 4 J Neurol 6 J Pediatr Endocrinol Metab 1 Lancet 4 Mult Scler 5 PLoS One 2 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. KUNCHOK A, Amin M, Ongphichetmetha T, Du M, et al
   Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD, MS and Healthy Controls, and Disability Associations.
   Ann Neurol. 2025 Jul 29. doi: 10.1002/ana.27309.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. WILSON S, Leray E, Calocer F, Rollot F, et al
   Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France.
   BMC Neurol. 2025;25:441.
   PubMed         Abstract available
   
   

   
   Brain

3. MASI G, Chen K, Bayer AC, Bayarri-Olmos R, et al
   IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathology.
   Brain. 2025 Oct 28:awaf410. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

4. ROJAS M, Acosta-Ampudia Y, Monsalve DM, Rami?rez-Santana C, et al
   Autoimmunity, epitope analysis, and molecular mimicry.
   Curr Opin Immunol. 2025;97:102681.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

5. WICKS MM, Wood AJ, Titmuss A, Shaw JE, et al
   Islet autoimmunity in young First Nations women with prediabetes and type 2 diabetes.
   Diabetes Res Clin Pract. 2025 Oct 29:112977. doi: 10.1016/j.diabres.2025.112977.
   PubMed         Abstract available
   
   
6. SAYGILI ES, Batman A, Karakilic E
   Predicting stimulated C-peptide in type 1 diabetes using machine learning: a web-based tool from the T1D exchange registry.
   Diabetes Res Clin Pract. 2025;229:112453.
   PubMed         Abstract available
   
   
7. XU Y, Chevreul K, Dindorf C, Bismuth E, et al
   Association of socioeconomic status and hospital efficiency in Type-1 diabetic patients with ketoacidosis or diabetic coma: a secondary data analysis comparing nation-wide paediatric and adult admissions in France.
   Diabetes Res Clin Pract. 2025;229:112450.
   PubMed         Abstract available
   
   
8. MALI LV, Malik JA, Sanchez J, Pendley JS, et al
   Behavioral self-control and glycemic levels in youth with type 1 diabetes: serial mediation by family conflict and self-management behaviors.
   Diabetes Res Clin Pract. 2025;229:112463.
   PubMed         Abstract available
   
   
9. PAPA G, Cannarella R, Gusmano C, Finocchiaro C, et al
   Effect of daily insulin delivery variability on glycemic outcomes in patients with type 1 diabetes mellitus using an automated insulin delivery system.
   Diabetes Res Clin Pract. 2025;229:112476.
   PubMed         Abstract available
   
   
10. SCHNEIDEWIND J, von Sengbusch S, Schmidt D, Lange K, et al
    Human factor in the use of automated insulin delivery systems: Real-world effects in children with type 1 diabetes after 2 years of use (AID-A study).
    Diabetes Res Clin Pract. 2025;229:112477.
    PubMed         Abstract available
    
    
11. GUO Y, Lin C, Cai X, Wu H, et al
    Regional, age-specific and sex-specific trends in the prevalence of overweight or obesity in type 1 diabetes from 1980 to 2020: a meta-analysis of 78 observational studies with 650,265 participants.
    Diabetes Res Clin Pract. 2025;229:112899.
    PubMed         Abstract available
    
    
12. JANUSZEWSKI AS, Rankin WA, O'Neal DN, Wittert GA, et al
    Sex hormone binging globulin as an indicator of insulin resistance in type 1 diabetes.
    Diabetes Res Clin Pract. 2025;229:112935.
    PubMed         Abstract available
    
    
13. BORON D, Mantaj U, Sibiak R, Gladych-Macioszek A, et al
    First-trimester continuous glucose monitoring parameters in preeclamptic and normotensive patients with type 1 diabetes.
    Diabetes Res Clin Pract. 2025;229:112944.
    PubMed         Abstract available
    
    
14. CAROSI ARCANGELI I, Ciavatta V, Celia G
    Self-efficacy among parents of children and adolescents with type 1 diabetes: a systematic review.
    Diabetes Res Clin Pract. 2025;229:112939.
    PubMed         Abstract available
    
    
15. PARK SH, Oh R, Kim S, Yang SH, et al
    Identification of clinically meaningful automatically detected postprandial glucose excursions in individuals with type 1 diabetes using personal continuous glucose monitoring.
    Diabetes Res Clin Pract. 2025;229:112951.
    PubMed         Abstract available
    
    
16. KASAHARA T, Nishikage S, Hirota Y, Nakatsuji M, et al
    Overweight and macrovascular complications in type 1 diabetes: A nationwide registry study (J?DREAMS).
    Diabetes Res Clin Pract. 2025;229:112956.
    PubMed         Abstract available
    
    

    
    Intern Med

17. MATSUBAYASHI T, Muramatsu R, Furuki M, Uchibori A, et al
    Hyperacute Guillain-Barre Syndrome Reaching Clinical Nadir Within 16 Hours: A Case Report.
    Intern Med. 2025 Oct 30. doi: 10.2169/internalmedicine.6349.
    PubMed         Abstract available
    
    
18. SHIGA T, Onishi K, Nagano H, Higashitani M, et al
    Poststreptococcal Glomerulonephritis Secondary to Bacterial Vaginosis, Complicated by Hemolytic Anemia and Thrombocytopenia: A Case Report.
    Intern Med. 2025 Oct 30. doi: 10.2169/internalmedicine.5748.
    PubMed         Abstract available
    
    

    
    J Autoimmun

19. AN X, Huang X
    Chimeric antigen receptor T cell therapy: a new frontier therapeutic landscape in autoimmune diseases.
    J Autoimmun. 2025;157:103495.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

20. CARRY PM, Kim S, Zwick NL, Buckner T, et al
    Increased Levels of the Vitamin D Metabolite Ratio are Protective Against Progression from Islet Autoimmunity to T1D.
    J Clin Endocrinol Metab. 2025 Oct 30:dgaf578. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Immunol

21. CHURCH ME, Hernandez SI, Alvarez JI
    Neuroinflammatory canine disorders: unveiling disease mechanisms from a One Health perspective.
    J Immunol. 2025;214:2535-2542.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

22. YU M, Zhang N, Chen C, He Y, et al
    Inflammatory ratios as early predictors of disease severity and immunotherapy response in autoimmune encephalitis.
    J Neuroimmunol. 2025;410:578786.
    PubMed         Abstract available
    
    
23. KARIGOWDA L, Brown D, Wong C, Deshpande K, et al
    Bortezomib for the treatment of anti-N-methyl-d-aspartate receptor encephalitis in a patient with psoriatic arthritis receiving adalimumab: A case report and literature review.
    J Neuroimmunol. 2025;409:578754.
    PubMed         Abstract available
    
    
24. ATASEVER U, Akunal C, Soyturk H
    Neuronal inflammation-associated biomarkers in cerebrospinal fluid of patients with acute and chronic inflammatory demyelinating polyneuropathies.
    J Neuroimmunol. 2025;409:578756.
    PubMed         Abstract available
    
    
25. SIWAN E, Tungpoomjaruswong A, Merheb V, Lee FXZ, et al
    Live MOG-IgG cell-based assay: Comparison across flow cytometers and diagnostic validation on high-sensitivity full spectrum flow cytometry.
    J Neuroimmunol. 2025;409:578760.
    PubMed         Abstract available
    
    
26. LUO H, Han Z, Yang J, Yang X, et al
    d-serine prevents cognitive impairment in a mouse model of NMDAR encephalitis.
    J Neuroimmunol. 2025;409:578768.
    PubMed         Abstract available
    
    
27. MARRODAN M, Perez Arana CI, Kirchner RJ, Varela FJ, et al
    Anti-NMDAR encephalitis across the lifespan: Clinical, electrophysiological, and prognostic insights from a Latin American cohort.
    J Neuroimmunol. 2025;409:578766.
    PubMed         Abstract available
    
    

    
    J Neurol

28. TAN Y, Lu J, Zhang J, Qi X, et al
    Efgartigimod-rituximab sequential therapy in Anti-NMDAR encephalitis: real-world evidence for a novel salvage-maintenance strategy.
    J Neurol. 2025;272:739.
    PubMed         Abstract available
    
    
29. LI Y, Zhou Q, Dong X, Duan W, et al
    Association between antibody status and exacerbation in patients with myasthenia gravis who achieved minimal manifestation or better status.
    J Neurol. 2025;272:736.
    PubMed         Abstract available
    
    
30. MONTE G, Tiralongo G, Papetti L, Ferilli MAN, et al
    Complete Epstein-Barr virus seropositivity in a cohort of pediatric onset multiple sclerosis: a comparison to other autoimmune diseases.
    J Neurol. 2025;272:735.
    PubMed         Abstract available
    
    
31. PALAZZO L, Cetta I, Bongiovanni L, Gastaldi M, et al
    Clinical and neuroradiological evolution of thymoma-associated anti-GABAA receptor autoimmune encephalitis: insights from a clinical case report.
    J Neurol. 2025;272:733.
    PubMed        
    
    

    
    J Pediatr Endocrinol Metab

32. DE CUYPER C, Staels W, Daelemans S, Vanbesien J, et al
    A case of JAGN1 mutation presenting with atypical diabetes and immunodeficiency.
    J Pediatr Endocrinol Metab. 2025;38:1217-1223.
    PubMed         Abstract available
    
    
33. WAMALWA P, Mungai L, Laigong P, Omar A, et al
    Annual case counts and clinical characteristics of pediatric and adolescent patients with diabetes in Kenyatta National Hospital, Nairobi, Kenya. A 14 year retrospective study.
    J Pediatr Endocrinol Metab. 2025;38:1154-1160.
    PubMed         Abstract available
    
    
34. KAMRATH C, Eckert AJ, Lignitz S, Hillenbrand N, et al
    Spatiotemporal associations between incidence of type 1 diabetes and COVID-19 vaccination rates in children in Germany - a population-based ecological study.
    J Pediatr Endocrinol Metab. 2025;38:1117-1125.
    PubMed         Abstract available
    
    
35. ODEH R, Alassaf A, Alhawari H, Jafar H, et al
    Immunogenetic profiling of type 1 diabetes in Jordan: a case-control study on HLA-associated risk and protection.
    J Pediatr Endocrinol Metab. 2025;38:1144-1153.
    PubMed         Abstract available
    
    
36. CHADER-GATA GARCIA A, Kaur K, Talib R, Salemi P, et al
    Impact of race and delayed adoption of diabetes technology on glycemia and partial remission in type 1 diabetes.
    J Pediatr Endocrinol Metab. 2025;38:1135-1143.
    PubMed         Abstract available
    
    
37. RUIZ JL, Asaro LA, Bernique AS, Healey E, et al
    Continuous glucose monitoring evidence of celiac disease in type 1 diabetes.
    J Pediatr Endocrinol Metab. 2025;38:1126-1134.
    PubMed         Abstract available
    
    

    
    Lancet

38. CACOUB P, Vieira M, Langford CA, Tazi Mezalek Z, et al
    Large-vessel vasculitis.
    Lancet. 2025;406:2017-2032.
    PubMed         Abstract available
    
    

    
    Mult Scler

39. ZIEMSSEN T, Freedman MS, Bar-Or A, Montalban X, et al
    Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis.
    Mult Scler. 2025 Oct 29:13524585251389797. doi: 10.1177/13524585251389797.
    PubMed         Abstract available
    
    
40. BANKS SA, Baker MR, Flanagan EP, Permezel FE, et al
    Tremor and disability outcomes following deep brain stimulation for multiple sclerosis-associated tremor.
    Mult Scler. 2025 Oct 27:13524585251387935. doi: 10.1177/13524585251387935.
    PubMed         Abstract available
    
    
41. BRIGGS FB, Yang J, Toljan K, Conway DS, et al
    Longitudinal modeling of upper extremity function in multiple sclerosis: Associations for clinical and sociodemographic factors.
    Mult Scler. 2025 Oct 26:13524585251384060. doi: 10.1177/13524585251384060.
    PubMed         Abstract available
    
    
42. CHERTCOFF AS, Ruiz-Alguero M, Yusuf F, Zhao Y, et al
    Psychiatric morbidity during the multiple sclerosis prodrome is associated with future disability.
    Mult Scler. 2025 Oct 26:13524585251382801. doi: 10.1177/13524585251382801.
    PubMed         Abstract available
    
    

    
    PLoS One

43. LTEIF MR, Kalot J, Jaouni ME, Khoury SJ, et al
    E-health literacy levels of multiple sclerosis patients in Lebanon.
    PLoS One. 2025;20:e0335084.
    PubMed         Abstract available
    
    
44. GRIMA AA, Hiraki LT, Bolotin S, Paterson AD, et al
    New onset autoimmune disease following a SARS-CoV-2 infection: A systematic review protocol.
    PLoS One. 2025;20:e0335766.
    PubMed         Abstract available
    
    
45. ALJOHANI N, Forbes A, Daqrashawi G, Due-Christensen M, et al
    'You decided I am old enough for the transition, but not old enough to have a say?': Exploring young people's, parents', and healthcare providers' views and experiences of Type 1 Diabetes paediatric to adult healthcare transition in Saudi Arabia.
    PLoS One. 2025;20:e0335347.
    PubMed         Abstract available
    
    
46. ZGLEJC-WASZAK K, Jastrzebski JP, Wojtkiewicz J, Pidsudko Z, et al
    Novel insights into neuropathy: The impact of prolonged hyperglycemia on long non-coding RNA expression.
    PLoS One. 2025;20:e0334245.
    PubMed         Abstract available
    
    
47. JIANG L, Jin Y, Han Y, Fu J, et al
    TRIM37-mediated stabilization of PEX5 via monoubiquitination attenuates oxidative stress and demyelination in multiple sclerosis insights from EAE and LPC-induced experimental models.
    PLoS One. 2025;20:e0335198.
    PubMed         Abstract available
    
    

    
    Thyroid

48. CARRETTI AL, Kielwasser G, Borson-Chazot F, Peiffert M, et al
    Teprotumumab Treatment in Patients with Steroid and Surgery-Resistant Dysthyroid Optic Neuropathy: A Case Series.
    Thyroid. 2025;35:1202-1207.
    PubMed         Abstract available
    
    
49. LEI C, Lyu X, Ren Y, Wei D, et al
    Clinical Features of Chinese Patients with Thyroid Eye Disease: A Multicenter Retrospective Study.
    Thyroid. 2025 Jul 14. doi: 10.1177/10507256251359559.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.